EPR Biotech News

Contact Us

EPR Biotech News is part of EPR Network and all questions, comments and general inquiries should be directed to EPR Network. Thank you for contacting us.

Pages

 

February 2012
M T W T F S S
« Jan    
 12345
6789101112
13141516171819
20212223242526
272829  

Advertisements

Categories

Recent Posts

Tags

Blogroll

Archives

Meta

January 25th 2012
Tags: Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Genetics, Pharmaceuticals

No Comments

Advinus, SignalChem Start The Multi-Year, Multi-Target Collaboration On New Anti-Cancer Drugs

Advinus Therapeutics, a research-based pharmaceutical development company promoted by the TATA Group, and SignalChem Pharmaceuticals, a British Columbia-based drug discovery company, have started working on 15 programs based on SignalChem’s proprietary Kinase platform for targeted therapies in oncology. Each program is being developed with corresponding diagnostics and tracers for patient ...
November 24th 2011
Tags: Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Genetics, Pharmaceuticals

No Comments

CYTOO Raises 10 M$ (7M€) in Series C Round

CYTOO SA, a company that specializes in cell-based assays, is pleased to announce the closing of a series C funding round of USD 10M (EUR 7M). New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors AURIGA Partners and Jacques Lewiner, co-founder and president of the supervisory board ...
November 22nd 2011
Tags: Biomedical Engineering, Biopharmaceutical, Biotech, Biotechnology, Healthcare, Medicine, Pharmaceuticals, Science

No Comments

GenQual Announces Initial Closing Of Its First Preferred Equity Funding Round

GenQual is pleased to announce initial closing of its first preferred equity round. Financial terms were not disclosed. This inaugural funding round allows GenQual to pursue proof-of-principle testing for its companion diagnostic approach for IL-6 mAb and other JAK/STAT inhibitors for autoimmune diseases and oncology indications. GenQual aims to prospectively ...
November 10th 2011
Tags: Biotech, Biotech Services, Biotechnology, DNA, Genetics, Genome, Medicine, Microarrays, Pharmaceuticals, RNA, Science

No Comments

Michigan Institute of Urology, P. C. to Perform Clinical Trial Using Cellay, Inc’s Same Day OligoFISH® Probes for Prostate Cancer

St. Clair Shores, Michigan and Cambridge, Massachusetts – Michigan Institute of Urology, P. C. (MIU) and Cellay, Inc. today announced that MIU will exclusively perform a clinical trial for prostate cancer using Cellay's Same Day OligoFISH® probe panel. Data from this trial will be included in Cellay's premarket approval (PMA) ...
September 27th 2011
Tags: Biochemicals, Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Solutions, Biotechnology, Healthcare, Licenses, Medical Technologies, Science

No Comments

Advanced Liquid Logic Licenses Patents, Creates Collaboration With CEA-Leti

Advanced Liquid Logic announced today that it has signed a license and collaboration agreement with the French research institute CEA-Leti. The agreement provides Advanced Liquid Logic with worldwide exclusive access to CEA’s portfolio of patents related to digital microfluidics. Advanced Liquid Logic co-founder and Dr. Michael Pollack said, “This agreement puts ...
June 9th 2011
Tags: Biotech, Biotech Services, Biotechnology, DNA, Genome, Microarrays, Proteomics, RNA, Science, Vaccines

No Comments

Enabling microRNA Discoveries - 250th Peer-Reviewed Publication Made Possible By µparaflo Custom Microarray Technology

LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery technologies, announced today the publication of over 250 peer-reviewed studies using the company’s microarray service for analyzing miRNA expression profiles. These studies, by leading researchers in the field, represent significant steps toward realizing these small ...
April 29th 2011
Tags: Biochemicals, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Healthcare, Medicine, Pharmaceuticals, Science

No Comments

Investor Stem Cell Launches Online Discussion Community Dedicated To Stem Cell Investors: (OTC-ACTC) (NASDAQ-GERN) (AMEX-BTX) (NASDAQ:ATHX)

Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people ...
March 23rd 2011
Tags: Biochemicals, Biomedical Engineering, Biopharmaceutical, Biotech, Biotechnology, Healthcare, Microarrays, Pharmaceuticals, Science

No Comments

MicroTissues, Inc. Announces New Product Launch for the 3D Petri Dish™

MicroTissues, Inc. announced today the launch of its 3D Petri Dish™ line of products. The 3D Petri Dish™ is a new tool for the world wide industry of life sciences research and drug discovery. Invented at Brown University, the 3D Petri Dish™ grows living human cells in three dimensions (3D) ...
March 9th 2011
Tags: Biochemicals, Biomedical Engineering, Biopharmaceutical, Biotech, Biotechnology, Healthcare, Microarrays, Pharmaceuticals, Science, Tissue Engineering

No Comments

MicroTissues, Inc.’s 3D Petri Dish™ Is Helping to Reduce Animal Use in Research

MicroTissues, Inc. announced today that its 3D Petri Dish™ is targeted towards helping to reduce the numbers of animals used in research. The 3D Petri Dish™ is a new tool for the world wide industry of life sciences research and drug discovery that grows living cells in three dimensions (3D). These ...
March 1st 2011
Tags: Biochemicals, Biomedical Engineering, Biopharmaceutical, Biotech, Biotechnology, Healthcare, Microarrays, Pharmaceuticals, Science, Tissue Engineering

No Comments

MicroTissues, Inc.’s 3D Petri Dish™ Used in Time Magazine’s Medical Breakthrough of 2010

MicroTissues, Inc. announced today that its 3D Petri Dish™ was used in one of Time magazine’s medical breakthroughs of 2010. Researchers at Brown University and Women and Infants Hospital used the 3D Petri Dish™ to invent the first artificial human ovary, a discovery important for fertility research and a possible infertility ...
January 24th 2011
Tags: Biopharmaceutical, Biotech, Biotech Services, Biotech Solutions, Biotechnology, Healthcare, Online, Pharmaceuticals, Science

No Comments

Assay-Ready Chemistry Partnership between Enamine and Molplex

Molplex and Enamine today announced a new partnership to offer the Enamine screening collection of 1.8 million stock chemicals through the Molplex online drug design and assay-ready chemical supply services. The agreement is a major step towards eliminating the high start-up costs ofdrug discovery, bringing sophisticated drug design, compound management and assay-ready chemistry to ...
January 24th 2011
Tags: Biochemicals, Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, DNA, Gene, Genome, Healthcare, Pharmaceuticals, Science

No Comments

Gene Therapy and Stem Cell Therapy Standard Developed For A Unique Derivative Of Post Hetero-Plastic Inplantation Chronic Inflammation Syndrome, The NIDO Disease

Researchers task force, led by faculties of T-Protocol, registered Genom Project as controlled genom project in the hosted database of NCBI, a publication matter authority and function assigned organization under oversee of Department of Health & Human Services, reached once to share the exegetical impression officially pre-published concerning the understanding ...
January 13th 2011
Tags: Biochemicals, Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, DNA, Gene, Genome, Healthcare, Pharmaceuticals, Science

No Comments

Nationaly Registered T-Protocol Of Genom Project Successfully Applied To Retrieve Bio Mechanism Of Hair Regrowth

Division of Gene Medicine & Stem Cell Application, School of Medical Science, complete the research and established completely new protocol totally recovering natural bio mechanism of hair regrowth. The researchers, led by Lord. Prof. Dr. Daichent Otto Rie, specified protein and genom to affect internal bio mechanism to generate hair and control ...
November 5th 2010
Tags: Biopharmaceutical, Biotech, Biotech Services, Biotech Solutions, Biotechnology, Healthcare, Online, Pharmaceuticals, Science

No Comments

Drug Discovery On Demand By Molplex

An innovative new online “drug discovery on demand” platform has been launched by Molplex, a company specializing in products and services for the life sciences. Designed to help drug discovery groups working anywhere in the world, it aimsto eliminate the high start-up costs and minimize the financial risks traditionally associated ...
September 23rd 2010
Tags: Biochemicals, Biomedical Engineering, Biopharmaceutical, Biotech, Biotechnology, Pharmaceuticals, Policy, Science

No Comments

Turkey’s Biopharmaceutical Sector Attracts, Boosts Research and Development Expenditures

A recent report on the biopharmaceutical sector presence, employment, economic output and research and development activity in the European States highlights Turkey’s long-term prospects for growth. The report notes that the industry is creating a positive ripple across the region’s economy, improving the quality of life for its citizens and ...
August 20th 2010
Tags: Biotech, Biotech Services, Biotechnology, DNA, Genome, Microarrays, Proteomics, RNA, Science, Vaccines

No Comments

The Porcine microRNAome is Revealed

Researchers from LC Sciences LLC and a collaboration of Universities1 have established a porcine microRNAome, a complete catalog of all microRNAs expressed in the species Sus scrofa2. MicroRNAs (miRNAs) are small regulatory RNA molecules known to control a wide array of cellular functions such as growth and development and whose ...
July 10th 2010
Tags: Biochemicals, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Healthcare, Medicine, Pharmaceuticals, Science

No Comments

Cryo-Cell CEO Mercedes Walton Invites Women to Share Their Ideas on Self-Care and the Power of Stem Cells

Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations about the promise of stem cells.  The company will be accepting video entries for its “Resolution Revolution” ...
July 10th 2010
Tags: Biochemicals, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Healthcare, Medicine, Pharmaceuticals, Science

No Comments

Cord Blood: Saving For The Future

For an expectant mother, there are a million details to worry about and a lot of important decisions to be made. One of those decisions to be made is whether to bank your baby's umbilical cord blood. Cord blood is valuable because it's full of stem cells scientists and doctors can use ...
July 10th 2010
Tags: Biochemicals, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Healthcare, Medicine, Pharmaceuticals, Science

No Comments

Scientist Uses Stem Cells To Repair Heart

Dr. Joshua Hare believes medicine is close to a goal long thought to be impossible: healing the human heart. The way to get there? Stem cells. "These could be as big as antibiotics were in the last century," said Hare, who leads the University of Miami 's new Stem Cell Institute. "Stem ...
July 10th 2010
Tags: Biochemicals, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Healthcare, Medicine, Pharmaceuticals, Science

No Comments

Will Intra-Osseous Injection of Umbilical Cord Blood Reduce Graft Failures?

Researchers from Italy have reported that the injection of umbilical cord blood directly into the pelvic bones of patients with leukemia appears promising. These results were recently published in an early online publication of the Lancet Oncology on August 9, 2008. Transplantation of bone marrow, peripheral blood stem cells, and umbilical cord blood is ...

Search

The archives run deep. Feel free to search older content using topic keywords.